Trial Profile
Pilot Efficacy and Safety Field Trial of Desloratadine Administered Concomitantly With Oxybutynin, in Subjects With Seasonal Allergic Rhinitis and Post-Nasal Drip
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary) ; Oxybutynin
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon; Schering-Plough
- 10 Jan 2009 New trial record.